Table 2.
Distribution of HLA-C alleles in patients with psoriasis and controls
| HLA-C | Psoriasis vulgaris (2n = 294) | Controls (2n = 214) | OR | 95 % CI | P cor | ||
|---|---|---|---|---|---|---|---|
| Count | f (%) | Count | f (%) | ||||
| *01 | 13 | 4.42 | 13 | 6.07 | 0.71 | 0.32–1.59 | n.s. |
| *02 | 11 | 3.74 | 12 | 5.61 | 0.66 | 0.28–1.52 | n.s. |
| *03 | 24 | 8.16 | 19 | 8.88 | 0.92 | 0.49–1.72 | n.s. |
| *04 | 42 | 14.29 | 34 | 15.89 | 0.88 | 0.54–1.45 | n.s. |
| *05 | 10 | 3.40 | 9 | 4.21 | 0.80 | 0.32–2.00 | n.s. |
| *06 | 69 | 23.47 | 16 | 7.48 | 3.85 | 2.13–6.67 | <0.0001 |
| *07 | 50 | 17.01 | 58 | 27.10 | 0.55 | 0.36–0.85 | n.s. |
| *08 | 2 | 0.68 | 7 | 3.27 | 0.20 | 0.04–0.99 | n.s. |
| *12 | 52 | 17.69 | 32 | 14.95 | 1.22 | 0.76–2.00 | n.s. |
| *14 | 1 | 0.34 | 0 | 0 | 2.19 | 0.09–54.12 | n.s. |
| *15 | 4 | 1.36 | 3 | 1.40 | 0.97 | 0.22–4.35 | n.s. |
| *16 | 13 | 4.42 | 4 | 1.87 | 2.44 | 0.78–7.69 | n.s. |
| *17 | 1 | 0.34 | 5 | 2.34 | 0.14 | 0.02–1.23 | n.s. |
| *18 | 2 | 0.68 | 2 | 0.93 | 0.72 | 0.10–5.26 | n.s. |
OR odds ratio, CI confidence interval, P cor corrected P value, n.s. not significant